These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26586448)
21. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Rode L; Klein K; Nicolaides KH; Krampl-Bettelheim E; Tabor A; Ultrasound Obstet Gynecol; 2011 Sep; 38(3):272-80. PubMed ID: 21739497 [TBL] [Abstract][Full Text] [Related]
22. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759 [TBL] [Abstract][Full Text] [Related]
23. Vaginal progesterone for preterm birth prevention in women with arrested preterm labor. Frey HA; Stout MJ; Abdelwahab M; Tuuli MG; Woolfolk C; Shamshirsaz AA; Macones GA; Cahill AG J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8160-8168. PubMed ID: 34407736 [TBL] [Abstract][Full Text] [Related]
24. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour. Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318 [TBL] [Abstract][Full Text] [Related]
25. Clarifying when to recommend progesterone to prevent preterm birth: clear as mud. Martinez de Tejada B; Cerutti B; Perneger T BJOG; 2015 Feb; 122(3):446-7. PubMed ID: 25623583 [No Abstract] [Full Text] [Related]
26. Clarifying when to recommend progesterone to prevent preterm birth: clear as mud. Norwitz ER BJOG; 2015 Jan; 122(1):92. PubMed ID: 25289941 [No Abstract] [Full Text] [Related]
27. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. O'Brien JM; Defranco EA; Adair CD; Lewis DF; Hall DR; How H; Bsharat M; Creasy GW; Ultrasound Obstet Gynecol; 2009 Dec; 34(6):653-9. PubMed ID: 19918965 [TBL] [Abstract][Full Text] [Related]
28. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial. Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363 [TBL] [Abstract][Full Text] [Related]
29. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial. Palacio M; Cobo T; Antolín E; Ramirez M; Cabrera F; Mozo de Rosales F; Bartha JL; Juan M; Martí A; Oros D; Rodríguez À; Scazzocchio E; Olivares JM; Varea S; Ríos J; Gratacós E; BJOG; 2016 Nov; 123(12):1990-1999. PubMed ID: 27028759 [TBL] [Abstract][Full Text] [Related]
30. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. O'Brien JM; Lewis DF Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340 [TBL] [Abstract][Full Text] [Related]
31. Progesterone for preterm birth prevention: an evolving intervention. Tita AT; Rouse DJ Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577 [TBL] [Abstract][Full Text] [Related]
32. Prediction and prevention of spontaneous preterm birth in twin gestations. Brubaker SG; Gyamfi C Semin Perinatol; 2012 Jun; 36(3):190-4. PubMed ID: 22713500 [TBL] [Abstract][Full Text] [Related]
33. Threatened preterm labour - analysis of the cytokine profile and progesterone treatment efficiency. Chmaj-Wierzchowska K; Olejniczak T; Tuzel J; Niepsuj-Biniaś J; Kaczorowska I; Samara H; Budna J; Dera-Szymanowska A; Olejniczak K; Szymanowski K J Matern Fetal Neonatal Med; 2017 Apr; 30(7):814-817. PubMed ID: 27151935 [TBL] [Abstract][Full Text] [Related]
34. Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial. Thongchan S; Phupong V BMC Pregnancy Childbirth; 2021 Jan; 21(1):90. PubMed ID: 33509129 [TBL] [Abstract][Full Text] [Related]
35. Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized Controlled Trial. Sirisangwon R; Phupong V Matern Child Health J; 2021 Jul; 25(7):1102-1109. PubMed ID: 33900515 [TBL] [Abstract][Full Text] [Related]
36. [What use of progesterone to prevent preterm birth?]. Legardeur H; Mandelbrot L; Kayem G Gynecol Obstet Fertil; 2013; 41(7-8):459-64. PubMed ID: 23876420 [TBL] [Abstract][Full Text] [Related]
37. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth. Glover MM; McKenna DS; Downing CM; Smith DB; Croom CS; Sonek JD Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990 [TBL] [Abstract][Full Text] [Related]
38. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Martinez de Tejada B; Karolinski A Am J Obstet Gynecol; 2015 Sep; 213(3):438-9. PubMed ID: 26003056 [No Abstract] [Full Text] [Related]
39. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery. Haram K; Mortensen JH; Morrison JC J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618 [TBL] [Abstract][Full Text] [Related]
40. Oral micronized progesterone for prevention of preterm birth. Rai P; Rajaram S; Goel N; Ayalur Gopalakrishnan R; Agarwal R; Mehta S Int J Gynaecol Obstet; 2009 Jan; 104(1):40-3. PubMed ID: 18929360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]